Dolby Laboratories, Inc. (DLB) Market Cap & Valuation Ratios
Dolby Laboratories, Inc. (DLB) has a market cap of $5.9B, a trailing P/E of 26.7 and a price-to-sales ratio of 4.3, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DLBDolby Laboratories, Inc.Follow DLB — free
—
Price chart with a free account
- Market cap
- 5.9B
- P/E TTM
- 26.7
- Dividend yield
- 2.2%
- 52-week
- —
- Next earnings
- 17 Nov, in 24 days
Peers
specialty business services · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| DLB | 5.9 | 26.7 | 3.9 | 15.7 | 6.7% | +0.6% | 18% | 10% |
| ARMK | 14 | 37.0 | 1.0 | 14.0 | 3.1% | +11% | 4% | 7% |
| WSE | 14 | — | — | — | — | +19% | 24% | — |
| ANDG | 7.2 | — | 8.0 | — | 2.3% | +15% | -7% | — |
| AMTM | 5.3 | 26.2 | 0.6 | 8.4 | 8.9% | +11% | 4% | 5% |
| UNF | 5.1 | 44.4 | 2.0 | 17.2 | 1.7% | +1% | 6% | 6% |
| AZZ | 4.0 | 23.8 | 2.5 | 11.6 | 5.4% | +9% | 16% | 11% |
| FA | 3.6 | — | 3.3 | 12.8 | 5.4% | +33% | 11% | 4% |
| MMS | 3.3 | 9.3 | 0.9 | 6.8 | 13.1% | -3% | 11% | 13% |
| ABM | 3.1 | 19.4 | 0.5 | 11.1 | 9.9% | +6% | 4% | 7% |
| CBZ | 3.0 | 26.8 | 1.6 | 14.7 | 9.2% | +14% | 7% | 4% |
| Median of these 10 | 26.2 | 1.6 | 12.2 | 5.4% | +11% | 7% | 6% |
P/E 26.7 vs. a peer median of 26.2; EV/Sales 3.9 vs. 1.6. DLB's own P/E sits at the 23rd percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesWSE and ANDG and FA have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Dolby Laboratories, Inc. — questions
- What is Dolby Laboratories, Inc.'s market cap?
- $5.9B.
- What is Dolby Laboratories, Inc.'s P/E ratio?
- 26.7 on trailing twelve-month earnings to 2026-06-30.
- What is Dolby Laboratories, Inc.'s price-to-sales ratio?
- 4.3.
Every figure on this page comes from Dolby Laboratories, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.